S&P 500   3,852.36
DOW   32,920.46
QQQ   290.27
Mullen Automotive On Hiring Spree, What Could That Mean? 
The Next Big Crisis Is Here (Ad)
What You Need to Know About Annuity Withdrawals
SoFi Technologies Smashes Earnings but Beware the Fed Decision
Is This The End of Capitalism? (Ad)
Why Extreme Networks is a Recession-Proof Technology Play
Why Gold Can Be A Glistening Addition To Your Portfolio Right Now
Is This The End of Capitalism? (Ad)
Grab Shares Are Suddenly On Track To Double
Buying The Dip In Colgate-Palmolive 
S&P 500   3,852.36
DOW   32,920.46
QQQ   290.27
Mullen Automotive On Hiring Spree, What Could That Mean? 
The Next Big Crisis Is Here (Ad)
What You Need to Know About Annuity Withdrawals
SoFi Technologies Smashes Earnings but Beware the Fed Decision
Is This The End of Capitalism? (Ad)
Why Extreme Networks is a Recession-Proof Technology Play
Why Gold Can Be A Glistening Addition To Your Portfolio Right Now
Is This The End of Capitalism? (Ad)
Grab Shares Are Suddenly On Track To Double
Buying The Dip In Colgate-Palmolive 
S&P 500   3,852.36
DOW   32,920.46
QQQ   290.27
Mullen Automotive On Hiring Spree, What Could That Mean? 
The Next Big Crisis Is Here (Ad)
What You Need to Know About Annuity Withdrawals
SoFi Technologies Smashes Earnings but Beware the Fed Decision
Is This The End of Capitalism? (Ad)
Why Extreme Networks is a Recession-Proof Technology Play
Why Gold Can Be A Glistening Addition To Your Portfolio Right Now
Is This The End of Capitalism? (Ad)
Grab Shares Are Suddenly On Track To Double
Buying The Dip In Colgate-Palmolive 
S&P 500   3,852.36
DOW   32,920.46
QQQ   290.27
Mullen Automotive On Hiring Spree, What Could That Mean? 
The Next Big Crisis Is Here (Ad)
What You Need to Know About Annuity Withdrawals
SoFi Technologies Smashes Earnings but Beware the Fed Decision
Is This The End of Capitalism? (Ad)
Why Extreme Networks is a Recession-Proof Technology Play
Why Gold Can Be A Glistening Addition To Your Portfolio Right Now
Is This The End of Capitalism? (Ad)
Grab Shares Are Suddenly On Track To Double
Buying The Dip In Colgate-Palmolive 
NASDAQ:SGRY

Surgery Partners - SGRY Stock Forecast, Price & News

$31.97
-0.67 (-2.05%)
(As of 01/30/2023 12:00 AM ET)
Add
Compare
Today's Range
$31.53
$32.21
50-Day Range
$25.41
$34.00
52-Week Range
$20.46
$63.87
Volume
424,218 shs
Average Volume
625,458 shs
Market Capitalization
$2.88 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$42.33

Surgery Partners MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.71 Rating Score
Upside/​Downside
32.4% Upside
$42.33 Price Target
Short Interest
Bearish
8.78% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.81mentions of Surgery Partners in the last 14 days
Based on 4 Articles This Week
Insider Trading
Acquiring Shares
$245,000 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.10) to $0.33 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.18 out of 5 stars

Medical Sector

464th out of 1,055 stocks

General Medical & Surgical Hospitals Industry

4th out of 5 stocks


SGRY stock logo

About Surgery Partners (NASDAQ:SGRY) Stock

Surgery Partners, Inc. is healthcare services holding company, which engages in the provision of solutions for surgical and related ancillary care in support of its patients and physicians. It operates through the following business segments: Surgical Facility Services, Ancillary Services, and Optical Services. The Surgical Facility Services segment consists of the operation of ambulatory surgery centers and surgical hospitals, including anesthesia services of the company. The Ancillary Services segment operates a diagnostic laboratory and multi-specialty physician practices. The Optical Services segment involves an optical laboratory and an optical products group purchasing organization. The company was founded in 2004 and is headquartered in Brentwood, TN.

Receive SGRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Surgery Partners and its competitors with MarketBeat's FREE daily newsletter.

SGRY Stock News Headlines

Surgery Partners (NASDAQ:SGRY) PT Lowered to $56.00 at Barclays
The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
Analyst Expectations for Surgery Partners's Future
Surgery Partners reaffirms FY22 guidance
The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
Board Member of Surgery Partners Makes $225.00M Buy
Surgery Partners Commences Public Offering Of Common Stock - Quick Facts
See More Headlines
Receive SGRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Surgery Partners and its competitors with MarketBeat's FREE daily newsletter.

SGRY Company Calendar

Last Earnings
11/08/2022
Today
1/30/2023
Next Earnings (Estimated)
2/27/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
General medical & surgical hospitals
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SGRY
Employees
10,900
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$42.33
High Stock Price Forecast
$56.00
Low Stock Price Forecast
$35.00
Forecasted Upside/Downside
+32.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.71
Research Coverage
7 Analysts

Profitability

Net Income
$-70,900,000.00
Pretax Margin
5.40%

Debt

Sales & Book Value

Annual Sales
$2.23 billion
Cash Flow
$0.99 per share
Book Value
$22.05 per share

Miscellaneous

Free Float
86,983,000
Market Cap
$2.88 billion
Optionable
Optionable
Beta
2.74

Key Executives

  • J. Eric Evans
    Chief Executive Officer & Director
  • David T. DohertyDavid T. Doherty
    Chief Financial Officer & Executive Vice President
  • Varun Gadhok
    Chief Information Officer & Senior Vice President
  • Roxanne Womack
    Chief Compliance Officer & Senior Vice President
  • Jennifer B. BaldockJennifer B. Baldock
    Secretary, Chief Administrative Officer & EVP













SGRY Stock - Frequently Asked Questions

Should I buy or sell Surgery Partners stock right now?

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Surgery Partners in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SGRY shares.
View SGRY analyst ratings
or view top-rated stocks.

What is Surgery Partners' stock price forecast for 2023?

7 brokerages have issued 1-year target prices for Surgery Partners' shares. Their SGRY share price forecasts range from $35.00 to $56.00. On average, they expect the company's share price to reach $42.33 in the next year. This suggests a possible upside of 32.4% from the stock's current price.
View analysts price targets for SGRY
or view top-rated stocks among Wall Street analysts.

How have SGRY shares performed in 2023?

Surgery Partners' stock was trading at $27.86 at the start of the year. Since then, SGRY stock has increased by 14.8% and is now trading at $31.97.
View the best growth stocks for 2023 here
.

When is Surgery Partners' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, February 27th 2023.
View our SGRY earnings forecast
.

How were Surgery Partners' earnings last quarter?

Surgery Partners, Inc. (NASDAQ:SGRY) posted its earnings results on Tuesday, November, 8th. The company reported ($0.08) EPS for the quarter, missing analysts' consensus estimates of ($0.01) by $0.07. The firm earned $620.60 million during the quarter, compared to analyst estimates of $622.97 million. Surgery Partners had a negative net margin of 1.28% and a negative trailing twelve-month return on equity of 0.51%.

What guidance has Surgery Partners issued on next quarter's earnings?

Surgery Partners updated its FY 2022 earnings guidance on Friday, January, 27th. The company provided EPS guidance of for the period. The company issued revenue guidance of $2.50 billion-$2.55 billion, compared to the consensus revenue estimate of $2.52 billion.

What is Eric Evans' approval rating as Surgery Partners' CEO?

7 employees have rated Surgery Partners Chief Executive Officer Eric Evans on Glassdoor.com. Eric Evans has an approval rating of 86% among the company's employees.

What other stocks do shareholders of Surgery Partners own?
What is Surgery Partners' stock symbol?

Surgery Partners trades on the NASDAQ under the ticker symbol "SGRY."

Who are Surgery Partners' major shareholders?

Surgery Partners' stock is owned by a number of institutional and retail investors. Top institutional investors include New York State Common Retirement Fund (0.04%), Assenagon Asset Management S.A. (0.03%), Wesbanco Bank Inc. (0.02%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Anthony Taparo, Brent Turner, David T Doherty, George Goodwin, Jason Eric Evans, Jennifer Baldock, Laura L Brocklehurst, Laura L Brocklehurst, Teresa Deluca, Thomas F Cowhey and Wayne S Deveydt.
View institutional ownership trends
.

How do I buy shares of Surgery Partners?

Shares of SGRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Surgery Partners' stock price today?

One share of SGRY stock can currently be purchased for approximately $31.97.

How much money does Surgery Partners make?

Surgery Partners (NASDAQ:SGRY) has a market capitalization of $2.88 billion and generates $2.44 billion in revenue each year. The company earns $-70,900,000.00 in net income (profit) each year or ($0.35) on an earnings per share basis.

How many employees does Surgery Partners have?

The company employs 10,900 workers across the globe.

How can I contact Surgery Partners?

Surgery Partners' mailing address is 310 Seven Springs Way Suite 500, Brentwood TN, 37027. The official website for the company is www.surgerypartners.com. The company can be reached via phone at (615) 234-5900, via email at ir@surgerypartners.com, or via fax at 615-234-5998.

This page (NASDAQ:SGRY) was last updated on 1/31/2023 by MarketBeat.com Staff